17123-74-9 Usage
General Description
3-(2-Acetoxyphenyl)propionic acid, also known as Zaltoprofen, is a non-steroidal anti-inflammatory drug (NSAID) with analgesic and anti-inflammatory properties. It is commonly used to treat pain and inflammation associated with conditions such as rheumatoid arthritis and osteoarthritis. The chemical works by inhibiting the synthesis of prostaglandins, which are hormone-like compounds that play a key role in the inflammatory response. This leads to a reduction in pain and swelling in affected areas. Zaltoprofen is typically administered orally in the form of tablets or capsules and is generally well-tolerated, with typical side effects including stomach upset and gastrointestinal discomfort. However, it may also pose a risk of more serious adverse effects, particularly in high doses or over prolonged periods of use, and should therefore be used with caution under the guidance of a healthcare professional.
Check Digit Verification of cas no
The CAS Registry Mumber 17123-74-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,1,2 and 3 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 17123-74:
(7*1)+(6*7)+(5*1)+(4*2)+(3*3)+(2*7)+(1*4)=89
89 % 10 = 9
So 17123-74-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H12O4/c1-8(12)15-11(14)7-6-9-4-2-3-5-10(9)13/h2-5,13H,6-7H2,1H3
17123-74-9Relevant articles and documents
COMPOUNDS AND COMPOSITIONS FOR OCULAR DELIVERY
-
Page/Page column 108; 217-219, (2020/05/12)
The present invention provides new prodrags of Sunitinib, Brinzolamide, and Dorzolamide and compositions to treat medical disorders, for example glaucoma, a disorder or abnormality related to an increase in intraocular pressure (TOP), a disorder requiring neuroprotection, age-related macular degeneration, or diabetic retinopathy.
Alpha-(2-alkoxyphenyl)-alpha-alkyl-1H-1,2,4-triazole-1-propanenitriles and derivatives
-
, (2008/06/13)
-
